s: Articles should not include an abstract. Please note that we will consider articles outside of the theme.The Residents’ Journal accepts manuscripts authored by medical students, resident physicians, and fellows; manuscripts authored by members of faculty cannot be accepted. Upcoming Issue Themes

As a treatment for tardive dyskinesia, sodium valproate was tested in a double-blind placebo-controlled parallel group trial, with 6-week base-line observation period followed by 6 weeks of treatment. Sodium valproate was not found to be an effective treatment for either tardive dyskinesia or drug-induced Parkinsonism, and did not affect mental state or behaviour.

BACKGROUND AND PURPOSE Dopamine agonists (DAs) are generally considered to be deprived of the highly dyskinetic effect of levodopa in Parkinson's disease (PD) patients. However, the risk for dyskinesia induced by DA monotherapy and the contribution of clinically significant factors in the development of this disorder have never been systematically assessed. METHODS A systematic literature sea...

Tardive dyskinesia is a potentially irreversible neurologic syndrome secondary to long-term neuroleptic drug use. It is characterized by slow. rhythmical. automatic stereotyped movements particularly in the buccolingual masticatory area. extremities. and trunk muscles in patients who have received neuroleptic drugs for at least three months. Unlike other neurologic side effects to neuroleptic d...

Background and Objectives: Chlorogenic acid, a natural polyphenolic compound has been reported to possess neuroprotective and antioxidant activities, but the effect of chlorogenic acid on orofacial dyskinesia has not been explored till date, so the aim of the present study was to investigate the effect of chlorogenic acid on reserpine-induced orofacial dyskinesia in Wistar male albino rats. Met...